Словакия -
словацкий -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
lipanthyl supra 160 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
Словакия -
словацкий -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
lipanthyl supra 215 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
Словакия -
словацкий -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
lipanthyl nt 145 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
Европейский союз -
словацкий -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Европейский союз -
словацкий -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Европейский союз -
словацкий -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Европейский союз -
словацкий -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Европейский союз -
словацкий -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Словакия -
словацкий -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
dimethyl fumarate glenmark 240 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata
Словакия -
словацкий -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
dimethyl fumarate glenmark 120 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata